Cardinal Health (CAH)

MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent, Zircaix®2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval.

Medical and surgical products manufacturer Stryker Co. (NYSESYK) is a beneficiary of the acute care boom occurring in the healthcare industry.

CAH stock is up after mixed earnings that investors hope is enough to hold support after the company announced its contract for OptumRx will expire in June

Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $114.82. So far today, approximately 39,979 shares have been exchanged, as compared to an average 30-day volume of 2.48M shares.

Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.

Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $91.04. So far today, approximately 1.64M shares have been exchanged, as compared to an average 30-day volume of 1.9M shares.

Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.

Many investors look at healthcare stocks, and particularly health insurance stocks, as the right prescription for an ailing portfolio

Shares of Cardinal Health, Inc. (NYSECAH) traded at a new 52-week high today and are currently trading at $94.25. So far today, approximately 578.71k shares have been exchanged, as compared to an average 30-day volume of 2.95M shares.

CLEVELAND, June 26, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective today, as Senior Vice President and Chief Financial Officer (“CFO”). Mr. Lyons recently served as Vice President, Corporate FP&A for Owens Corning (NYSEOC), a nearly $10 billion global building and construction materials leader. Prior to this role, Mr. Lyons was Vice President and Finance leader for Owens Corning’s $3.7 billion Insulation business and the company’s $2.7 billion Composites business. He was previously also the company’s Treasurer. Mr. Lyons has also held several senior leadership roles in treasury, FP&A, investor relations and tax during his 8-year career at Cardinal Health NYSE: CAHNYSECAH)

Cardinal Health is on the rise after raising guidance and announcing a new repurchase program worth more than 10% of the market cap.

LONDON, April 27, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced it has selected Cardinal Health Inc. (NYSECAH) to support the launch and commercialization of its CAR T-cell therapies in the United States, subject to FDA approval.

Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.

By David Willey, Benzinga

Collaboration connects My.RxLive tool to the OutcomesOne™ platform to improve communication and drive better patient outcomes, reducing readmission and unnecessary cost.

By David Willey, Benzinga

Stocks are staging a rally to end the week. But economic data next week may bring more volatility. Here are some of the most popular articles from this week

EQNX::TICKER_START (NASDAQSTSS),NYSE:BDXNYSEBDX)(NYSE:CAHNYSECAH,(NYSE:NVONYSE),(OTCPK:TRUMY),(NASDAQ:STSSWSTSSW) EQNX::TICKER_END

Cardinal Health, which distributes branded and generic pharmaceuticals and other healthcare products, cleared a cup-with-handle buy point Wednesday.

Shares of Cardinal Health Inc. (NYSECAH) traded today at $72.28, eclipsing its 52-week high. This new high was reached on below average trading volume as 830,000 shares traded hands, while the average 30-day volume is approximately 2.9 million shares.

Social media companies have been hit hard and Pinterest is no exception. But its biggest investor, which holds a 9% stake, voiced confidence in the company.

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem

AmerisourceBergen (NYSEABC), Cardinal Health NYSE: CAHNYSECAH)(NYSE: MCKNYSEMCK announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington’s allocation under the previously announced comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities, as well as certain attorneys’ fees and costs.